Literature DB >> 19961519

Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.

Akira Tari1, Hideki Asaoku, Kozo Kashiwado, Tadashi Yoshino, Yasuhiko Kitadai, Shinji Tanaka, Megumu Fujihara.   

Abstract

BACKGROUND: Some gastric diffuse large B-cell lymphomas have been reported to regress completely after the successful eradication of Helicobacter pylori. The aim of this study was to investigate the clinical characteristics of gastric diffuse large B-cell lymphomas without any detectable mucosa-associated lymphoid tissue (MALT) lymphoma that went into complete remission after successful H. pylori eradication. PATIENTS AND METHODS: We examined the effect of H. pylori eradication in 15 H. pylori-positive gastric diffuse large B-cell lymphoma patients without any evidence of an associated MALT lymphoma (clinical stage I by the Lugano classification) by endoscopic examination including biopsies, endoscopic ultrasonography, computed tomography, and bone marrow aspiration.
RESULTS: H. pylori eradication was successful in all the patients and complete remission was achieved in four patients whose clinical stage was I. By endoscopic examination, these gastric lesions appeared to be superficial. The depth by endoscopic ultrasonography was restricted to the mucosa in two patients and to the shallow portion of the submucosa in the other two patients. All four patients remained in complete remission for 7-100 months.
CONCLUSION: In gastric diffuse large B-cell lymphomas without a concomitant MALT lymphoma but associated with H. pylori infection, only superficial cases and lesions limited to the shallow portion of the submucosa regressed completely after successful H. pylori eradication. The endoscopic appearance and the rating of the depth of invasion by endosonography are both valuable for predicting the efficacy of H. pylori eradication in treating gastric diffuse large B-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961519     DOI: 10.1111/j.1443-1661.2009.00896.x

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  3 in total

Review 1.  De-escalating therapy in gastric aggressive lymphoma.

Authors:  Rosanna Cuccurullo; Silvia Govi; Andrés J M Ferreri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

2.  Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma.

Authors:  Tomoko Miyata-Takata; Katsuyoshi Takata; Tomohiro Toji; Naoe Goto; Senji Kasahara; Takeshi Takahashi; Akira Tari; Mai Noujima-Harada; Takafumi Miyata; Yasuharu Sato; Tadashi Yoshino
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

3.  Exosomal CagA from Helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression.

Authors:  Yinjie Guo; Canxia Xu; Renjie Gong; Tingzi Hu; Xue Zhang; Xiaoran Xie; Jingshu Chi; Huan Li; Xiujuan Xia; Xiaoming Liu
Journal:  Gut Pathog       Date:  2022-03-24       Impact factor: 4.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.